The European study on centralisation of childhood cancer treatment
Gemma Gatta(Fondazione IRCCS Istituto Nazionale dei Tumori), Riccardo Capocaccia(Fondazione Progetto Ematologia), Laura Botta(Fondazione IRCCS Istituto Nazionale dei Tumori), Tina Žagar(Institute of Oncology Ljubljana), Kathy Pritchard‐Jones(Cancer Research UK), Annalisa Trama(Fondazione IRCCS Istituto Nazionale dei Tumori), Otto Visser(Netherlands Comprehensive Cancer Organisation), Liesbet Van Eycken, Maarit K. Leinonen(University of Helsinki), Sabine Siesling(Netherlands Comprehensive Cancer Organisation), Harry Comber(Universidad de Granada), Jan Maarten van der Zwan(Netherlands Comprehensive Cancer Organisation), Nadya Dimitrova(Istituto Superiore di Sanità)
Cited by 28
Related Papers
Current and future burden of breast cancer: Global statistics for 2020 and 2040
|The Breast|2022|3.3k
The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers
|European Journal of Cancer|2021|650
The expression of the Wilms' tumour gene, WT1, in the developing mammalian embryo
|Mechanisms of Development|1993|590
Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study
|The Lancet Oncology|2017|510
Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study
|European Journal of Cancer|2015|486